Chitosan–polycarbophil interpolyelectrolyte complex as a matrix former for controlled release of poorly water-soluble drugs I: in vitro evaluation

References

• Mandal TK. (2000). Swelling-controlled release system for the vaginal delivery of miconazole. Eur J Pharm Biopharm, 50:337–43.
   PubMed Web of Science ®Google Scholar
• Jantzen GM, Robinson JR. (2002). Sustained- and controlled-release drug-delivery systems. In: Banker GS, Rhodes CT, eds. Modern pharmaceutics. New York: Marcel Dekker, Inc., 501–28.
   Google Scholar
• Collet J, Moreton C. (2002). Modified release peroral dosage form. In: Aulton ME, ed. Pharmaceutics the science of dosage form design. Edinburgh: Churchill Livingstone, 289–306.
   Google Scholar
• Colombo P, Bettini R, Santi P, Peppas NA. (2000). Swellable matrices for controlled drug delivery: Gel-layer behaviour, mechanisms and optimal performance. Pharm Sci Technol Today, 3:198–204.
   PubMedGoogle Scholar
• Jamzad S, Fassihi R. (2006). Development of a controlled release low dose class II drug-Glipizide. Int J Pharm, 312:24–32.
   PubMed Web of Science ®Google Scholar
• Colombo P. (1993). Swelling-controlled release in hydrogel matrices for oral route. Adv Drug Deliv Rev, 11:37–57.
   Web of Science ®Google Scholar
• Siepmann J, Peppas NA. (2001). Modeling of drug release from delivery systems based on hydroxylpropyl methylcellulose (HPMC). Adv Drug Deliv Rev, 48:139–57.
   PubMed Web of Science ®Google Scholar
• Ford JL, Rubinstein MH, McCaul F, Hogan JE, Edgar PJ. (1987). Importance of drug type, tablet shape and added diluents on drug release kinetics from hydroxylpropyl methylcellulose matrix tablets. Int J Pharm, 40:223–34.
   Web of Science ®Google Scholar
• Rao KVR, Padmalatha Devi K, Buri P. (1990). Influence of molecular size and water solubility of the solute on its release from swelling and erosion controlled polymeric matrices. J Control Release, 12:133–41.
   Web of Science ®Google Scholar
• Tahara K, Yamamoto K, Nishihata T. (1995). Overall mechanism behind matrix sustained release (SR) tablets prepared with hydroxylpropylmethylcellulose 2910. J Control Release, 35:59–66.
   Web of Science ®Google Scholar
• Reynolds TD, Gehrke SH, Hussain AS, Shenouda LS. (1998). Polymer erosion and drug release characterization of hydroxylpropyl methylcellulose matrices. J Pharm Sci, 87:1115–23.
   PubMed Web of Science ®Google Scholar
• Siepmann J, Kranz H, Bodmeier R, Peppas NA. (1999). HPMC matrices for controlled drug delivery: A new model combining diffusion, swelling and dissolution mechanisms and predicting the release kinetics. Pharm Res, 16:1748–56.
   PubMed Web of Science ®Google Scholar
• Peppas NA, Khare AR. (1993). Preparation, structure and diffusion behaviour of hydrogels in controlled release. Adv Drug Deliv Rev, 11:1–35.
   Web of Science ®Google Scholar
• Berger J, Reist M, Mayer JM, Felt O, Peppas NA, Gurny R. (2004). Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications. Eur J Pharm Biopharm, 57:19–34.
   PubMed Web of Science ®Google Scholar
• Nam K, Watanabe J, Ishihara K. (2004). The characteristics of spontaneously forming physically cross-linked hydrogels composed of two water-soluble phospholipid polymers for oral drug delivery carrier I: Hydrogel dissolution and insulin release under neutral pH condition. Eur J Pharm Sci, 23:261–70.
   PubMed Web of Science ®Google Scholar
• Moustafine RI, Kabanova TV, Kemenova VA, Van den Mooter G. (2005). Characteristics of interpolyelectrolyte complexes of Eudragit E100 with Eudragit L100. J Control Release, 103:191–8.
   PubMed Web of Science ®Google Scholar
• Paul W, Sharma CP. (2000). Chitosan, a drug carrier for the 21st century: A review. STP Pharm Sci, 10:5–22.
   Google Scholar
• Dumitriu S, Chornet E. (1998). Inclusion and release of proteins from polysaccharide-based polyion complexes. Adv Drug Deliv Rev, 31:223–46.
   PubMed Web of Science ®Google Scholar
• Margulis EB, Moustafine RI. (2006). Swellability testing of chitosan/Eudragit® L100-55 interpolyelectrolyte complexes for colonic drug delivery. J Control Release, 116:e36–7.
   PubMed Web of Science ®Google Scholar
• Sankalia MG, Mashru RC, Sankalia JM, Sutariya VB. (2007). Reversed chitosan–alginate polyelectrolyte complex for stability improvement of alpha-amylase: Optimization and physicochemical characterization. Eur J Pharm Biopharm, 65:215–32.
   PubMed Web of Science ®Google Scholar
• Lu Z, Chen W, Hamman JH. (2007). Chitosan–polycarbophil complexes in swellable matrix systems for controlled drug release. Curr Drug Deliv, 4:257–63.
   PubMedGoogle Scholar
• Lu Z, Chen W, Olivier EI, Hamman JH. (2008). Matrix polymeric excipients: Comparing a novel interpolyelectrolyte complex with hydroxypropylmethylcellulose. Drug Deliv, 15:87–96.
   PubMed Web of Science ®Google Scholar
• Lu Z, Chen W, Hamman JH, Ni J, Zhai X. (2008). Chitosan-polycarbophil interpolyelectrolyte complex as an excipient for bioadhesive matrix systems to control macromolecular drug delivery. Pharm Dev Technol, 13:37–47.
   PubMed Web of Science ®Google Scholar
• United States Pharmacopoeia 29 (USP). (2006). Rockville: United States Pharmacopeial Convention, Inc.
   Google Scholar
• Ritger PL, Peppas NA. (1987). A simple equation for description of solute release. II Fickian and anomalous release from swellable devices. J Control Release, 5:37–42.
   Google Scholar
• Pillay V, Fassihi R. (1999). A new method for dissolution studies of lipid filled capsules employing nifedipine as a model drug. Pharm Res, 16:333–8.
   PubMed Web of Science ®Google Scholar
• Peppas NA. (1985). Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv, 60:110–1.
   PubMedGoogle Scholar
• Reppas C, Nicolaides E. (2000). Analysis of drug dissolution data. In: Dressman JB, Lennernäs H, eds. Oral drug absorption prediction and assessment. New York: Marcel Dekker, Inc., 229–54.
   Google Scholar
• Sousa JJ, Sousa A, Moura MJ, Podczeck F, Nowton JM. (2002). The influence of core materials and film coating on the drug release from coated pellets. Int J Pharm, 233:111–22.
   PubMed Web of Science ®Google Scholar